CoChat

Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations

Lipitz‐Snyderman, Allison, Chimonas, Susan, Mailankody, Sham, Kim, Michelle, Silva, Nicholas, Kriplani, Anuja, Saltz, Leonard B., Sihag, Smita, Tan, Carlyn Rose, Widmar, Maria, Zauderer, Marjorie, Weingart, Saul, Perchick, Wendy, Roman, Benjamin R. · 2023 · Cancer Medicine
Cited by 10

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: Data on the clinical value of second opinions in oncology are limited. We examined diagnostic and treatment changes resulting from second opinions and the expected impact on morbidity and prognosis. Methods: This retrospective cohort study included patients presenting in 2018 to a high‐volume cancer center for second opinions about newly diagnosed colorectal, head and neck, lung, and myeloma cancers or abnormal results. Two sub‐specialty physicians from each cancer type reviewed 30 medical records (120 total) using a process and detailed data collection guide meant to mitigate institutional bias. The primary outcome measure was the rate of treatment changes that were “clinically meaningful”, i.e., expected to impact morbidity and/or prognosis. Among those with treatment changes, another outcome measure was the rate of clinically meaningful diagnostic changes that led to treatment change. Results: Of 120 cases, forty‐two had clinically meaningful changes in treatment with positive expected outcomes (7 colorectal, 17 head and neck, 11 lung, 7 myeloma; 23–57%). Two patients had negative expected outcomes from having sought a second opinion, with worse short‐term morbidity and unchanged long‐term morbidity and prognosis. All those with positive expected outcomes had improved expected morbidity (short‐ and/or long‐term); 11 (0–23%) also had improved expected prognosis. Nine involved a shift from treatment to observation; 21 involved eliminating or reducing the extent of surgery, compared to 6 adding surgery or increasing its extent. Of the 42 with treatment changes, 13 were due to clinically meaningful diagnostic changes (1 colorectal, 5 head and neck, 3 lung, 4 myeloma; 3%–17%) . Conclusions: Second‐opinion consultations sometimes add clinical value by improving expected prognoses; more often, they offer treatment de‐escalations, with corresponding reductions in expected short‐ and/or long‐term morbidity. Future research could identify subgroups of patients most likely to benefit from second opinions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cam4.5598

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. 10.1056/NEJMp1512241 · DOI · Paper page
  2. 10.1016/j.amjmed.2015.04.020 · DOI
  3. 10.1245/s10434-018-6599-y · DOI
  4. 10.1016/j.mayocp.2014.02.015 · DOI
  5. 10.1007/s00432-015-2099-7 · DOI
  6. 10.1007/s00345-010-0602-y · doi:10.1007/s00345-010-0602-y
  7. 10.1016/j.ejso.2005.08.007 · DOI
  8. 10.2214/AJR.16.16871 · DOI
  9. 10.1016/s0029-7844(99)00318-x · DOI · Paper page
  10. 10.1155/2020/9810170 · DOI
  11. 10.1136/bmjqs-2014-003675 · DOI · Paper page
  12. 10.5694/j.1326-5377.2009.tb02754.x · doi:10.5694/j.1326-5377.2009.tb02754.x
  13. 10.1200/JCO.2003.12.058 · doi:10.1200/jco.2003.12.058
  14. 10.1186/s12904-020-00619-9 · DOI
  15. 10.1097/md.0000000000009411 · doi:10.1097/md.0000000000009411
  16. 10.1016/j.acra.2017.12.010 · doi:10.1016/j.acra.2017.12.010
  17. 10.1007/s00261-018-1765-z · doi:10.1007/s00261-018-1765-z
  18. 10.1016/j.jacr.2018.05.008 · doi:10.1016/j.jacr.2018.05.008
  19. 10.1097/mnm.0000000000000647 · doi:10.1097/mnm.0000000000000647
  20. 10.1007/s00330-015-4040-5 · DOI
  21. 10.1002/cncr.30083 · DOI
  22. 10.1016/j.clinimag.2018.06.012 · doi:10.1016/j.clinimag.2018.06.012
  23. 10.2214/ajr.14.13600 · DOI
  24. 10.1002/hed.26719 · doi:10.1002/hed.26719
  25. 10.1634/theoncologist.2020-0213 · DOI · Paper page
  26. 10.1056/NEJM199102073240604 · DOI · Paper page
  27. 10.1002/cncr.30916 · DOI

Metadata

Authors
Lipitz‐Snyderman, A., Chimonas, S., Mailankody, S., Kim, M., Silva, N., Kriplani, A., Saltz, L. B., Sihag, S., Tan, C. R., Widmar, M., Zauderer, M., Weingart, S., Perchick, W., & Roman, B. R.
Venue
Cancer Medicine
Publisher
Wiley
Published
2023-02-03
Volume
12
Issue
7
Pages
8063-8072
ISSN
2045-7634
Cited by
10
References
3
Language
en
Funders
National Institutes of Health (P30 CA008748)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.